Catecholaminergic Polymorphic Ventricular Tachycardia.

Marwan M Refaat, Sylvana Hassanieh, Melvin Scheinman

Journal: Cardiac electrophysiology clinics 2016;8(1):233-7

PMID: 26920200

Full Text on Elsevier Science View on PubMed

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a challenging and serious disease with a high incidence of sudden cardiac deaths. Patients with CPVT should not be exposed to physical or emotional exertion that might induce ventricular tachycardia. This article presents a case with CPVT and discusses the clinical features of the disease, its genetic background, and the management of CPVT.

Address: Cardiology, Department of Internal Medicine, American University of Beirut Faculty of Medicine and Medical Center, PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: [email protected].; Department of Biochemistry and Molecular Genetics, American University of Beirut Medical Center, Beirut, Lebanon.; Division of Cardiology, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA, USA.

DOI: 10.1016/j.ccep.2015.10.035

Link outs

Free resources

Medical:

https://medlineplus.gov/genetics/condition/catecho...

Other Literature Sources:

https://scite.ai/reports/26920200

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Electrocardiography, Female, Humans, Mutation, Ryanodine Receptor Calcium Release Channel, Syncope, Tachycardia, Ventricular, Polymorphic Catecholaminergic Ventricular Tachycardia